Serum Lipid Profiles of Patients Taking Efavirenz-Based Antiretroviral Regimen Compared to Ritonavir-Boosted Atazanavir with an Optimized Background at Zewditu Memorial Hospital, Addis Ababa, Ethiopia

BACKGROUND: Dyslipidemia represents significant health care concerns in patients taking antiretroviral therapy due to their association with cardiovascular disease risk. There is limited data regarding the effects of boosted atazanavir (ATV/r) treatment in the lipid profiles of Ethiopian HIV patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Muche Belete, Abebe, Seifu, Daniel, Menon, Menakath, Amogne, Wondwossen, Shewa, Aster, Adela Tefera, Alemu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903961/
https://www.ncbi.nlm.nih.gov/pubmed/33642881
http://dx.doi.org/10.2147/HIV.S296170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903961/
https://www.ncbi.nlm.nih.gov/pubmed/33642881
http://dx.doi.org/10.2147/HIV.S296170

Ejemplares similares